Institute of Clinical Medicine - News

The Biomarker Laboratory at the University of Eastern Finland Brain Research Unit is launching diagnostics for a biomarker of Alzheimer’s disease, to be measured from a blood sample.

The goal of the study starting in January is to determine whether the new vaccine generates sufficient antibodies against the SARS-CoV-2 virus and its variants, and to ensure the vaccine’s safety.

“We should roll up our sleeves to strengthen primary healthcare. Specialised healthcare cannot make up for what’s lacking in statutory basic public services,” says Professor of Public Health Medicine Harri Hyppölä.

The Research Council of Finland grants competitive funding to Finnish universities to support them in strengthening their research profiles.

Persistent over-dilation of muscle microvasculature may be one reason causing chronic limb-threatening ischemia. This surprising finding may offer new avenues for screening and treatment.

Awards were presented to the MoLeWe Research Collective, to Professor Markku Hauta-Kasari, Senior University Lecturer Lasse Heikkinen and University Lecturer Ville Nivalainen in recognition of their communication related to the university’s education in technology, to Professor Tomi Voutilainen, and to the Multidisciplinary Cancer Research Community, CANCER RC.

In all, the Finnish Research Infrastructure Committee within the Research Council of Finland selected 21 infrastructures to the roadmap of national research infrastructures 2025–2028.

The findings of the dissertation provide timely insight into the T-cell landscape at different stages of T1D progression.

A large new population study of men over 45 indicates insulin resistance may be an important risk factor for the development of the world’s most common heart valve disease – aortic stenosis.

The PhD thesis demonstrates high PCNSL incidence in Finland. Considering the poor prognosis, rapid treatment initiation is crucial for disease control.